Oliver Hankinson - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Pathology, Molecular Biology

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yamaguchi M, Hankinson O. An aryl hydrocarbon receptor agonist suppresses the growth of human umbilical vein endothelial cells in vitro: Potent effect with polyunsaturated fatty acids. International Journal of Experimental Pathology. PMID 32985761 DOI: 10.1111/iep.12373  0.318
2020 Huerta-Yepez S, Tirado-Rodriguez A, Montecillo-Aguado MR, Yang J, Hammock BD, Hankinson O. Aryl Hydrocarbon Receptor-Dependent inductions of omega-3 and omega-6 polyunsaturated fatty acid metabolism act inversely on tumor progression. Scientific Reports. 10: 7843. PMID 32398692 DOI: 10.1038/S41598-020-64146-6  0.42
2019 Sundberg CD, Hankinson O. A CRISPR/Cas9 whole-genome screen identifies genes required for Aryl Hydrocarbon Receptor-dependent induction of functional CYP1A1. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 31086989 DOI: 10.1093/Toxsci/Kfz111  0.465
2019 Yamaguchi M, Hankinson O. 2,3,7,8‑tetrachlorodibenzo‑p‑dioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling. International Journal of Oncology. PMID 30720065 DOI: 10.3892/Ijo.2019.4703  0.406
2018 Yamaguchi M, Osuka S, Hankinson O, Murata T. Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro. International Journal of Oncology. PMID 30387835 DOI: 10.3892/Ijo.2018.4611  0.434
2018 Yamaguchi M, Hankinson O. 2,3,7,8‑Tetrachlorodibenzo‑p‑dioxin suppresses the growth of human liver cancer HepG2 cells in vitro: Involvement of cell signaling factors. International Journal of Oncology. 53: 1657-1666. PMID 30066859 DOI: 10.3892/Ijo.2018.4507  0.423
2018 Beischlag TV, Prefontaine GG, Hankinson O. ChIP-re-ChIP: Co-occupancy Analysis by Sequential Chromatin Immunoprecipitation. Methods in Molecular Biology (Clifton, N.J.). 1689: 103-112. PMID 29027168 DOI: 10.1007/978-1-4939-7380-4_9  0.302
2016 Hankinson O. The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids. Drug Metabolism Reviews. 1-9. PMID 27358009 DOI: 10.1080/03602532.2016.1197240  0.446
2014 Solaimani P, Wang F, Hankinson O. SIN3A, generally regarded as a transcriptional repressor, is required for induction of gene transcription by the aryl hydrocarbon receptor. The Journal of Biological Chemistry. 289: 33655-62. PMID 25305016 DOI: 10.1074/Jbc.M114.611236  0.835
2013 Yang J, Solaimani P, Dong H, Hammock B, Hankinson O. Treatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung. The Journal of Toxicological Sciences. 38: 833-6. PMID 24213002 DOI: 10.2131/Jts.38.833  0.795
2013 Solaimani P, Damoiseaux R, Hankinson O. Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicological Sciences : An Official Journal of the Society of Toxicology. 136: 107-19. PMID 23997114 DOI: 10.1093/Toxsci/Kft191  0.82
2013 Ingelman-Sundberg M, Zhong XB, Hankinson O, Beedanagari S, Yu AM, Peng L, Osawa Y. Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1725-31. PMID 23918665 DOI: 10.1124/Dmd.113.053157  0.781
2012 Baay-Guzman GJ, Bebenek IG, Zeidler M, Hernandez-Pando R, Vega MI, Garcia-Zepeda EA, Antonio-Andres G, Bonavida B, Riedi M, Kleerup E, Tashkin DP, Hankinson O, Huerta-Yepez S. HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: Implications in allergic airway inflammation Respiratory Research. 13. PMID 22823210 DOI: 10.1186/1465-9921-13-60  0.786
2012 Bui P, Solaimani P, Wu X, Hankinson O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicology and Applied Pharmacology. 259: 143-51. PMID 22230337 DOI: 10.1016/J.Taap.2011.12.009  0.778
2012 Bebenek IG, Solaimani P, Bui P, Hankinson O. CYP2S1 is negatively regulated by corticosteroids in human cell lines. Toxicology Letters. 209: 30-4. PMID 22155357 DOI: 10.1016/J.Toxlet.2011.11.020  0.782
2012 Hankinson O. The role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon receptor action. Trends in Endocrinology and Metabolism: Tem. 5: 240-4. PMID 18407214 DOI: 10.1016/1043-2760(94)P3082-I  0.364
2011 Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, Riedl M, Diaz-Sanchez D, Kleerup E, Tashkin DP, Gonzalez FJ, Bonavida B, Zeidler M, Hankinson O. Hypoxia Inducible Factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis Allergy: European Journal of Allergy and Clinical Immunology. 66: 909-918. PMID 21517900 DOI: 10.1111/J.1398-9995.2011.02594.X  0.756
2011 Quesada A, Bui PH, Homanics GE, Hankinson O, Handforth A. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. European Journal of Pharmacology. 659: 30-6. PMID 21256842 DOI: 10.1016/J.Ejphar.2011.01.004  0.772
2011 Bui P, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 180-90. PMID 21068195 DOI: 10.1124/Dmd.110.035121  0.758
2011 Hankinson O. ARNT (aryl hydrocarbon receptor nuclear translocator) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/38129  0.347
2010 Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Molecular Pharmacology. 78: 608-16. PMID 20631054 DOI: 10.1124/Mol.110.064899  0.797
2010 Wang F, Zhang R, Wu X, Hankinson O. Roles of coactivators in hypoxic induction of the erythropoietin gene. Plos One. 5: e10002. PMID 20368990 DOI: 10.1371/Journal.Pone.0010002  0.354
2010 Beedanagari SR, Taylor RT, Hankinson O. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. Toxicology Letters. 194: 26-33. PMID 20116417 DOI: 10.1016/J.Toxlet.2010.01.019  0.815
2010 Shi S, Yoon DY, Hodge-Bell K, Huerta-Yepez S, Hankinson O. Aryl hydrocarbon nuclear translocator (hypoxia inducible factor 1beta) activity is required more during early than late tumor growth. Molecular Carcinogenesis. 49: 157-65. PMID 19824022 DOI: 10.1002/Mc.20585  0.78
2009 Shi S, Yoon DY, Hodge-Bell KC, Bebenek IG, Whitekus MJ, Zhang R, Cochran AJ, Huerta-Yepez S, Yim SH, Gonzalez FJ, Jaiswal AK, Hankinson O. The aryl hydrocarbon receptor nuclear translocator (Arnt) is required for tumor initiation by benzo[a]pyrene. Carcinogenesis. 30: 1957-61. PMID 19755658 DOI: 10.1093/Carcin/Bgp201  0.776
2009 Bui PH, Hankinson O. Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Molecular Pharmacology. 76: 1031-43. PMID 19713358 DOI: 10.1124/Mol.109.057752  0.81
2009 Bui PH, Hsu EL, Hankinson O. Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Molecular Pharmacology. 76: 1044-52. PMID 19713357 DOI: 10.1124/Mol.109.057760  0.776
2009 Hankinson O. Repression of aryl hydrocarbon receptor transcriptional activity by epidermal growth factor. Molecular Interventions. 9: 116-8. PMID 19592671 DOI: 10.1124/Mi.9.3.4  0.527
2009 Beedanagari SR, Bebenek I, Bui P, Hankinson O. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicological Sciences : An Official Journal of the Society of Toxicology. 110: 61-7. PMID 19376845 DOI: 10.1093/Toxsci/Kfp079  0.791
2009 Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT, Hankinson O. Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by Phytochemicals. Journal of Oncology. 2009: 491985. PMID 19325924 DOI: 10.1155/2009/491985  0.666
2009 Büchler P, Reber HA, Tomlinson JS, Hankinson O, Kallifatidis G, Friess H, Herr I, Hines OJ. Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia (New York, N.Y.). 11: 196-206. PMID 19177204 DOI: 10.1593/Neo.08734  0.462
2009 Taylor RT, Wang F, Hsu EL, Hankinson O. Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 107: 1-8. PMID 18842620 DOI: 10.1093/Toxsci/Kfn217  0.748
2008 Bui PH, Quesada A, Handforth A, Hankinson O. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1291-9. PMID 18411403 DOI: 10.1124/Dmd.107.020115  0.748
2008 Hankinson O. Why does ARNT2 behave differently from ARNT? Toxicological Sciences : An Official Journal of the Society of Toxicology. 103: 1-3. PMID 18397918 DOI: 10.1093/Toxsci/Kfn032  0.461
2008 Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT, Hankinson O. CXCR4 and CXCL12 down-regulation: a novel mechanism for the chemoprotection of 3,3'-diindolylmethane for breast and ovarian cancers. Cancer Letters. 265: 113-23. PMID 18378071 DOI: 10.1016/J.Canlet.2008.02.033  0.66
2007 Wang F, Zhang R, Shi S, Hankinson O. The effect of aromatic hydrocarbon receptor on the phenotype of the Hepa 1c1c7 murine hepatoma cells in the absence of dioxin. Gene Regulation and Systems Biology. 1: 49-56. PMID 19936078 DOI: 10.4137/Grsb.S0  0.449
2007 Wang F, Zhang R, Xia T, Hsu E, Cai Y, Gu Z, Hankinson O. Inhibitory effects of nitric oxide on invasion of human cancer cells. Cancer Letters. 257: 274-82. PMID 17869411 DOI: 10.1016/J.Canlet.2007.08.001  0.656
2007 Rivera SP, Saarikoski ST, Sun W, Hankinson O. Identification of novel dioxin-responsive genes by representational difference analysis. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 37: 271-9. PMID 17624025 DOI: 10.1080/00498250601169816  0.811
2007 Hsu EL, Yoon D, Choi HH, Wang F, Taylor RT, Chen N, Zhang R, Hankinson O. A proposed mechanism for the protective effect of dioxin against breast cancer. Toxicological Sciences : An Official Journal of the Society of Toxicology. 98: 436-44. PMID 17517823 DOI: 10.1093/Toxsci/Kfm125  0.777
2007 Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R, Hankinson O. A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. The Journal of Biological Chemistry. 282: 10881-93. PMID 17277313 DOI: 10.1074/Jbc.M609617200  0.807
2006 Wang F, Shi S, Zhang R, Hankinson O. Identifying target genes of the aryl hydrocarbon receptor nuclear translocator (Arnt) using DNA microarray analysis. Biological Chemistry. 387: 1215-8. PMID 16972789 DOI: 10.1515/Bc.2006.150  0.443
2005 Saarikoski ST, Rivera SP, Hankinson O, Husgafvel-Pursiainen K. CYP2S1: a short review. Toxicology and Applied Pharmacology. 207: 62-9. PMID 16054184 DOI: 10.1016/J.Taap.2004.12.027  0.813
2005 Rivera SP, Choi HH, Chapman B, Whitekus MJ, Terao M, Garattini E, Hankinson O. Identification of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes. Toxicology. 207: 401-9. PMID 15664268 DOI: 10.1016/J.Tox.2004.10.009  0.826
2005 Hankinson O. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics. 433: 379-86. PMID 15581594 DOI: 10.1016/J.Abb.2004.09.031  0.466
2004 Fretland AJ, Safe S, Hankinson O. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7. Chemico-Biological Interactions. 150: 161-70. PMID 15535986 DOI: 10.1016/J.Cbi.2004.09.007  0.498
2004 Beischlag TV, Taylor RT, Rose DW, Yoon D, Chen Y, Lee WH, Rosenfeld MG, Hankinson O. Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia. The Journal of Biological Chemistry. 279: 54620-8. PMID 15485806 DOI: 10.1074/Jbc.M410456200  0.81
2004 Wang F, Zhang R, Beischlag TV, Muchardt C, Yaniv M, Hankinson O. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. The Journal of Biological Chemistry. 279: 46733-41. PMID 15347669 DOI: 10.1074/Jbc.M409002200  0.41
2004 Wang S, Ge K, Roeder RG, Hankinson O. Role of mediator in transcriptional activation by the aryl hydrocarbon receptor. The Journal of Biological Chemistry. 279: 13593-600. PMID 14729673 DOI: 10.1074/Jbc.M312274200  0.493
2002 Saarikoski ST, Rivera SP, Hankinson O. Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia. Febs Letters. 530: 186-90. PMID 12387890 DOI: 10.1016/S0014-5793(02)03475-0  0.815
2002 Beischlag TV, Wang S, Rose DW, Torchia J, Reisz-Porszasz S, Muhammad K, Nelson WE, Probst MR, Rosenfeld MG, Hankinson O. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Molecular and Cellular Biology. 22: 4319-33. PMID 12024042 DOI: 10.1128/Mcb.22.12.4319-4333.2002  0.452
2002 Rivera SP, Saarikoski ST, Hankinson O. Identification of a novel dioxin-inducible cytochrome P450. Molecular Pharmacology. 61: 255-9. PMID 11809848 DOI: 10.1124/Mol.61.2.255  0.815
2002 Wang S, Hankinson O. Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex. The Journal of Biological Chemistry. 277: 11821-7. PMID 11805098 DOI: 10.1074/Jbc.M110122200  0.479
2001 Yoon DY, Buchler P, Saarikoski ST, Hines OJ, Reber HA, Hankinson O. Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochemical and Biophysical Research Communications. 288: 882-6. PMID 11688991 DOI: 10.1006/Bbrc.2001.5867  0.795
2001 Anttila S, Tuominen P, Hirvonen A, Nurminen M, Karjalainen A, Hankinson O, Elovaara E. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics. 11: 501-9. PMID 11505220 DOI: 10.1097/00008571-200108000-00005  0.33
2001 Lei XD, Chapman B, Hankinson O. Loss of cyp1a1 messenger rna expression due to nonsense-mediated decay. Molecular Pharmacology. 60: 388-93. PMID 11455027 DOI: 10.1124/Mol.60.2.388  0.395
2001 Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. American Journal of Respiratory Cell and Molecular Biology. 24: 339-44. PMID 11245634 DOI: 10.1165/Ajrcmb.24.3.4252  0.405
2001 Heo Y, Saxon A, Hankinson O. Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice. Toxicology. 159: 143-58. PMID 11223170 DOI: 10.1016/S0300-483X(00)00418-2  0.331
2001 Anttila S, Lei XD, Elovaara E, Karjalainen A, Sun W, Vainio H, Hankinson O. An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics. 10: 741-51. PMID 11186136 DOI: 10.1097/00008571-200011000-00008  0.364
1998 Sun W, Zhang J, Hankinson O. A mutation in the aryl hydrocarbon receptor (AHR) in a cultured mammalian cell line identifies a novel region of AHR that affects DNA binding. The Journal of Biological Chemistry. 272: 31845-54. PMID 9395531 DOI: 10.1074/Jbc.272.50.31845  0.365
1997 Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 94: 8104-9. PMID 9223322 DOI: 10.1073/Pnas.94.15.8104  0.412
1997 Probst MR, Fan CM, Tessier-Lavigne M, Hankinson O. Two murine homologs of the Drosophila single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator protein. The Journal of Biological Chemistry. 272: 4451-7. PMID 9020169 DOI: 10.1074/Jbc.272.7.4451  0.426
1996 Sindhu RK, Reisz-Porszasz S, Hankinson O, Kikkawa Y. Induction of cytochrome P4501A1 by photooxidized tryptophan in Hepa lclc7 cells Biochemical Pharmacology. 52: 1883-1893. PMID 8951347 DOI: 10.1016/S0006-2952(97)81491-8  0.424
1996 Wood SM, Gleadle JM, Pugh CW, Hankinson O, Ratcliffe PJ. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxie induction of gene expression: Studies in arnt-deficient cells Journal of Biological Chemistry. 271: 15117-15123. PMID 8662957 DOI: 10.1074/Jbc.271.25.15117  0.458
1996 Fukunaga BN, Hankinson O. Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding. The Journal of Biological Chemistry. 271: 3743-9. PMID 8631989 DOI: 10.1074/Jbc.271.7.3743  0.328
1996 Bacsi SG, Hankinson O. Functional characterization of DNA-binding domains of the subunits of the heterodimeric aryl hydrocarbon receptor complex imputing novel and canonical basic helix-loop-helix protein-DNA interactions. The Journal of Biological Chemistry. 271: 8843-50. PMID 8621524 DOI: 10.1074/Jbc.271.15.8843  0.307
1996 Fukunaga BN, Probst MR, Reisz-Porszasz S, Hankinson O. Identification of functional domains of the aryl hydrocarbon receptor. The Journal of Biological Chemistry. 270: 29270-8. PMID 7493958 DOI: 10.1074/Jbc.270.49.29270  0.355
1995 Hankinson O. The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and Toxicology. 35: 307-40. PMID 7598497 DOI: 10.1146/Annurev.Pa.35.040195.001515  0.44
1994 Reisz-Porszasz S, Probst MR, Fukunaga BN, Hankinson O. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Molecular and Cellular Biology. 14: 6075-86. PMID 8065341 DOI: 10.1128/Mcb.14.9.6075  0.344
1994 Hankinson O. A genetic analysis of processes regulating cytochrome P4501A1 expression. Advances in Enzyme Regulation. 34: 159-71. PMID 7942273 DOI: 10.1016/0065-2571(94)90015-9  0.461
1993 Johnson B, Brooks BA, Heinzmann C, Diep A, Mohandas T, Sparkes RS, Reyes H, Hoffman E, Lange E, Gatti A, Xia YR, Lusis AJ, Hankinson O. The Ah Receptor Nuclear Translocator Gene (ARNT) Is Located on q21 of Human Chromosome 1 and on Mouse Chromosome 3 near Cf-3 Genomics. 17: 592-598. PMID 8244375 DOI: 10.1006/Geno.1993.1377  0.308
1992 Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science (New York, N.Y.). 256: 1193-5. PMID 1317062 DOI: 10.1126/Science.256.5060.1193  0.369
1992 Watson AJ, Weir-Brown KI, Bannister RM, Chu FF, Reisz-Porszasz S, Fujii-Kuriyama Y, Sogawa K, Hankinson O. Mechanism of action of a repressor of dioxin-dependent induction of Cyp1a1 gene transcription. Molecular and Cellular Biology. 12: 2115-23. PMID 1314949 DOI: 10.1128/Mcb.12.5.2115  0.437
1992 Johnson BS, Brooks BA, Reyes H, Hoffman EC, Hankinson O. An Mspl RFLP in the human ARNT gene, encoding a subunit of the nuclear form of the ah (dioxin) receptor Human Molecular Genetics. 1: 351. PMID 1284629 DOI: 10.1093/Hmg/1.5.351  0.369
1991 Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA, Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science (New York, N.Y.). 252: 954-8. PMID 1852076 DOI: 10.1126/Science.1852076  0.356
1991 Hankinson O, Brooks BA, Weir-Brown KI, Hoffman EC, Johnson BS, Nanthur J, Reyes H, Watson AJ. Genetic and molecular analysis of the Ah receptor and of Cyp1a1 gene expression Biochimie. 73: 61-66. PMID 1851644 DOI: 10.1515/Jbcpp.1992.3.S1.8  0.421
1988 Watson AJ, Hankinson O. DNA transfection of a gene repressing aryl hydrocarbon hydroxylase induction. Carcinogenesis. 9: 1581-6. PMID 3409461 DOI: 10.1093/Carcin/9.9.1581  0.318
1987 Gudas JM, Hankinson O. Regulation of cytochrome P-450c in differentiated and dedifferentiated rat hepatoma cells: role of the Ah receptor. Somatic Cell and Molecular Genetics. 13: 513-28. PMID 2821631 DOI: 10.1007/Bf01534493  0.477
1986 Gudas JM, Hankinson O. Reversible inactivation of the Ah receptor associated with changes in intracellular ATP levels. Journal of Cellular Physiology. 128: 449-56. PMID 3018004 DOI: 10.1002/Jcp.1041280314  0.37
1986 Gudas JM, Karenlampi SO, Hankinson O. Intracellular location of the Ah receptor. Journal of Cellular Physiology. 128: 441-8. PMID 3018003 DOI: 10.1002/Jcp.1041280313  0.367
1984 Van Gurp JR, Hankinson O. Isolation and characterization of revertants from four different classes of aryl hydrocarbon hydroxylase-deficient hepa-1 mutants. Molecular and Cellular Biology. 4: 1597-604. PMID 6493230 DOI: 10.1128/Mcb.4.8.1597  0.33
1984 Nebert DW, Eisen HJ, Hankinson O. The Ah receptor: binding specificity only for foreign chemicals? Biochemical Pharmacology. 33: 917-24. PMID 6324804 DOI: 10.1016/0006-2952(84)90446-5  0.427
1983 Duthu GS, Hankinson O. The defects in all classes of aryl hydrocarbon hydroxylase-deficient mutant of mouse hepatoma line, Hepa-1, are restricted to activities catalyzed by cytochrome P-450. Cancer Letters. 20: 249-54. PMID 6627226 DOI: 10.1016/0304-3835(83)90021-6  0.345
1983 Duthu GS, Nestor MS, Berliner JA, Philpot RM, Hankinson O. Characterization of NADPH-cytochrome P-450 reductase in a mouse hepatoma cell line. Cancer Letters. 18: 237-43. PMID 6303557 DOI: 10.1016/0304-3835(83)90231-8  0.383
Show low-probability matches.